pillbase.ru

Lifyorli

Active substance: relacorilant

relacorilant

Centralised EU authorisationActive

Marketing holder: Corcept Therapeutics Netherlands B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • Lifyorli
    KIT · relacorilant
    76346-425
    Corcept Therapeutics Incorporated
  • Lifyorli
    KIT · relacorilant
    76346-525
    Corcept Therapeutics Incorporated
  • Lifyorli
    KIT · relacorilant
    76346-550
    Corcept Therapeutics Incorporated
  • Lifyorli
    KIT · relacorilant
    76346-450
    Corcept Therapeutics Incorporated
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-c39b-78b3-b102-c07f48e59414,01a12097-5da6-7494-ac35-e355fa8e297c,01a12097-5dab-72ca-b993-51ccb3bd4a18,01a1209c-311f-76a5-bfd9-054c59dbfa7d;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006731
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/006731 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006731 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006731 · Verified 2026-10-09